Clinical Trial Update: The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of omega-3 fatty acids on peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of California, San Francisco | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED